Arena Pharmaceuticals (ARNA) Volatile as FDA Minutes from May 10 Panel Posted

June 25, 2012 1:07 PM EDT
Trader chatter on Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) is picking up after biotech watcher Adam Feuerstein of the notes that minutes from the May 10th FDA panel on lorcaserin have been posted.

He notes on Twitter, "The approved FDA panel minutes don't show lorcaserin in such a nice light. Many panelists "reluctantly voted yes..."

Investors are waiting on the 6/27 PDUFA date for drug approval.

Link to minutes and other material.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Trader Talk

Related Entities


Add Your Comment